Mirum Pharmaceuticals, Inc. (MIRM)
96.40
-0.50
(-0.52%)
USD |
NASDAQ |
Apr 15, 16:00
96.42
+0.02
(+0.02%)
Pre-Market: 20:00
Mirum Pharmaceuticals Shareholders Equity (Quarterly) : 314.69M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BridgeBio Pharma, Inc. | -2.087B |
| BioMarin Pharmaceutical, Inc. | 6.087B |
| Insmed, Inc. | 738.98M |
| Ionis Pharmaceuticals, Inc. | 489.09M |
| Cogent Biosciences, Inc. | 636.37M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 842.81M |
| Total Liabilities (Quarterly) | 528.12M |
| Debt to Equity Ratio | 1.015 |
| Current Ratio | 2.671 |
| Net Debt Paydown Yield | -0.01% |